← back to search

Donald Richards

Cedars-Sinai Medical Center · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, and Advanced Breast Cancer Therapies.
h-index
54
citations
16,155
works
392
NIH funding
primary concept
Medicine
email

Recent publications

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study
Journal of Clinical Oncology 2025cited by 33position: middledoi
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
˜The œLancet. Gastroenterology & hepatology 2025cited by 4position: middledoi
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
Journal of Clinical Oncology 2024cited by 148position: middledoi
On Wilks' joint moment formulas for embedded principal minors of Wishart random matrices
Stat 2024cited by 3position: contributordoi
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
The Lancet Oncology 2023cited by 238position: middledoi
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy
Journal of Thoracic Oncology 2023cited by 37position: middledoi
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
The Lancet Oncology 2021cited by 182position: middledoi
A Basic Treatment of the Distance Covariance
Sankhya B 2021cited by 2position: lastdoi
The distance standard deviation
The Annals of Statistics 2020cited by 4position: middledoi
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Annals of Oncology 2019cited by 167position: middledoi
Integral transform methods in goodness-of-fit testing, I: the gamma distributions
Metrika 2019cited by 7position: contributordoi
Loading monotonicity of weighted premiums, and total positivity properties of weight functions
Journal of Mathematical Analysis and Applications 2019cited by 3position: contributordoi
Distance correlation coefficients for Lancaster distributions
Journal of Multivariate Analysis 2016cited by 12position: lastdoi
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
The Lancet 2015cited by 1,186position: middledoi
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
Annals of Oncology 2014cited by 132position: middledoi
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
Annals of Oncology 2012cited by 190position: middledoi

Grants

Distance Correlation Measures, with Applications to Astrophysical Databases and Diffusion Tensor Imaging
NSF1309808$195,0002013–2016PIRePORTER
Multivariate Statistical Analysis and Image Classification with Applications
NSF0705210$290,0002007–2010PIRePORTER
Harmonic Analysis and Special Functions
NSF9703705$99,0001997–2000PIRePORTER
Mathematical Sciences: Harmonic Analysis and Special Functions
NSF9401322$98,2261994–1997PIRePORTER
Mathematical Sciences: Research in Generalized Special Functions
NSF9101740$93,0851991–1995PIRePORTER
Mathematical Sciences: Research in Generalized Special Functions
NSF8802929$47,5971988–1991PIRePORTER
Mathematical Sciences: Generalized Special Functions
NSF8601671$29,9001986–1988PIRePORTER

Frequent collaborators

Dominic Edelmann · German Cancer Research Center3 papers (2016–2021) · 3 papers (2019–2024)Edward B. Garon · Cancer Clinic2 papers (2012–2023)Allen Lee Cohn · Canon (United States)2 papers (2014–2025)Wade T. Iams · Twitter (United States)1 papers (2023–2023)Shirish M. Gadgeel · The Barbara Ann Karmanos Cancer Institute1 papers (2023–2023)David S. Hong · The University of Texas MD Anderson Cancer Center1 papers (2023–2023) · 1 papers (2016–2016)David Berz · Brown University1 papers (2023–2023)Lionel Aurelien Kankeu Fonkoua · Mayo Clinic1 papers (2025–2025)Manish R. Patel · University of Minnesota, Twin Cities1 papers (2023–2023) · 1 papers (2025–2025)Christos Fountzilas · Roswell Park Comprehensive Cancer Center1 papers (2025–2025)Jean Fan · Transgenomic (United States)1 papers (2025–2025) · 1 papers (2014–2014)Jesse McGreivy · Amgen (United States)1 papers (2012–2012)Gary Middleton · University of Oxford1 papers (2014–2014)Daneng Li · City Of Hope National Medical Center1 papers (2025–2025) · 1 papers (2014–2014)Peter Olson · Bristol-Myers Squibb (Germany)1 papers (2023–2023)